GoodRx/$GDRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About GoodRx
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Ticker
$GDRX
Sector
Primary listing
Employees
738
Headquarters
Website
GoodRx Metrics
BasicAdvanced
$916M
31.22
$0.09
1.46
-
Price and volume
Market cap
$916M
Beta
1.46
52-week high
$5.81
52-week low
$2.61
Average daily volume
2.5M
Financial strength
Current ratio
3.11
Quick ratio
2.994
Long term debt to equity
89.123
Total debt to equity
90.748
Interest coverage (TTM)
2.47%
Profitability
EBITDA (TTM)
132.723
Gross margin (TTM)
93.46%
Net profit margin (TTM)
3.97%
Operating margin (TTM)
13.46%
Effective tax rate (TTM)
40.93%
Revenue per employee (TTM)
$1,080,000
Management effectiveness
Return on assets (TTM)
5.03%
Return on equity (TTM)
4.90%
Valuation
Price to earnings (TTM)
31.217
Price to revenue (TTM)
1.238
Price to book
1.53
Price to tangible book (TTM)
-35.57
Price to free cash flow (TTM)
9.447
Free cash flow yield (TTM)
10.59%
Free cash flow per share (TTM)
0.286
Growth
Revenue change (TTM)
1.30%
Earnings per share change (TTM)
-298.46%
3-year revenue growth (CAGR)
0.21%
3-year earnings per share growth (CAGR)
-20.35%
What the Analysts think about GoodRx
Analyst ratings (Buy, Hold, Sell) for GoodRx stock.
GoodRx Financial Performance
Revenues and expenses
GoodRx Earnings Performance
Company profitability
GoodRx News
AllArticlesVideos
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
Business Wire·3 weeks ago
GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx
PYMNTS·1 month ago
Should You Buy GoodRx Stock?
Forbes·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GoodRx stock?
GoodRx (GDRX) has a market cap of $916M as of December 10, 2025.
What is the P/E ratio for GoodRx stock?
The price to earnings (P/E) ratio for GoodRx (GDRX) stock is 31.22 as of December 10, 2025.
Does GoodRx stock pay dividends?
No, GoodRx (GDRX) stock does not pay dividends to its shareholders as of December 10, 2025.
When is the next GoodRx dividend payment date?
GoodRx (GDRX) stock does not pay dividends to its shareholders.
What is the beta indicator for GoodRx?
GoodRx (GDRX) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.